What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in Q1 2022?

219 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock for Q1 2022. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class: Equity / Common Stock
Shares outstanding: 251,185,504
Total 13F shares: 127,644,333
Share change: +9,685,054
Total reported value: $2,074,127,946
Put/Call ratio: 48%
Price per share: $16.26
Number of holders: 219
Value change: +$162,394,498
Number of buys: 102
Number of sells: 87

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2022
Previous quarter: Q4 2021

Recent filing periods for CUSIP 09058V103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	5.9%	14,787,395	$204,805,000	—	31 Dec 2021	13F
BAKER BROS. ADVISORS LP	13F	Company	5.1%	12,710,818	$176,045,000	—	31 Dec 2021	13F
VANGUARD GROUP INC	13F	Company	3.7%	9,412,905	$130,369,000	—	31 Dec 2021	13F
STATE STREET CORP	13F	Company	3.3%	8,249,029	$114,249,000	—	31 Dec 2021	13F
PICTET ASSET MANAGEMENT SA	13F	Company	2%	5,055,264	$70,015,000	—	31 Dec 2021	13F
Fisher Asset Management, LLC	13F	Company	1.6%	4,097,052	$56,744,000	—	31 Dec 2021	13F
Sarissa Capital Management LP	13F	Company	1.6%	4,039,600	$55,948,000	—	31 Dec 2021	13F
FMR LLC	13F	Company	1.6%	3,896,248	$53,963,000	—	31 Dec 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	3,218,476	$44,575,000	—	31 Dec 2021	13F
RP Management, LLC	13F	Company	1.5%	3,846,154	$43,000,000	—	31 Dec 2021	13F
Artisan Partners Limited Partnership	13F	Company	1.1%	2,841,230	$39,351,000	—	31 Dec 2021	13F
HealthCor Management, L.P.	13F	Company	0.95%	2,377,130	$32,923,000	—	31 Dec 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.94%	2,360,925	$32,698,000	—	31 Dec 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.86%	2,151,912	$29,804,000	—	31 Dec 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.79%	1,995,984	$27,645,000	—	31 Dec 2021	13F
BNP Paribas Asset Management Holding S.A.	13F	Company	0.75%	1,891,160	$26,193,000	—	31 Dec 2021	13F
NORTHERN TRUST CORP	13F	Company	0.74%	1,861,008	$25,775,000	—	31 Dec 2021	13F
STIFEL FINANCIAL CORP	13F	Company	0.74%	1,849,524	$25,616,000	—	31 Dec 2021	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.67%	1,686,140	$23,353,000	—	31 Dec 2021	13F
ORACLE INVESTMENT MANAGEMENT INC	13F	Company	0.67%	1,670,733	$23,140,000	—	31 Dec 2021	13F
Sofinnova Investments, Inc.	13F	Company	0.6%	1,510,473	$20,920,000	—	31 Dec 2021	13F
LOOMIS SAYLES & CO L P	13F	Company	0.57%	1,437,112	$19,904,000	—	31 Dec 2021	13F
Bain Capital Public Equity Management II, LLC	13F	Company	0.57%	1,427,377	$19,769,000	—	31 Dec 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.51%	1,274,815	$17,657,000	—	31 Dec 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.49%	1,223,189	$16,941,000	—	31 Dec 2021	13F
D. E. Shaw & Co., Inc.	13F	Company	0.45%	1,132,265	$15,682,000	—	31 Dec 2021	13F
Granahan Investment Management, LLC	13F	Company	0.45%	1,130,578	$15,659,000	—	31 Dec 2021	13F
Bank of New York Mellon Corp	13F	Company	0.34%	857,932	$11,882,000	—	31 Dec 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.32%	813,660	$11,270,000	—	31 Dec 2021	13F
NORGES BANK	13F	Company	0.29%	717,674	$9,940,000	—	31 Dec 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.28%	693,830	$9,610,000	—	31 Dec 2021	13F
MPM BioImpact LLC	13F	Company	0.26%	661,951	$9,168,000	—	31 Dec 2021	13F
OSAIC HOLDINGS, INC.	13F	Company	0.22%	560,499	$7,764,000	—	31 Dec 2021	13F
UBS Group AG	13F	Company	0.21%	532,650	$7,377,000	—	31 Dec 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.18%	452,637	$6,269,000	—	31 Dec 2021	13F
North Star Investment Management Corp.	13F	Company	0.18%	449,800	$6,230,000	—	31 Dec 2021	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.18%	441,266	$6,112,000	—	31 Dec 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.16%	400,001	$5,540,000	—	31 Dec 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.16%	398,373	$5,518,000	—	31 Dec 2021	13F
Swiss National Bank	13F	Company	0.16%	392,568	$5,437,000	—	31 Dec 2021	13F
CITIGROUP INC	13F	Company	0.15%	388,878	$5,386,000	—	31 Dec 2021	13F
MORGAN STANLEY	13F	Company	0.15%	376,369	$5,213,000	—	31 Dec 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.14%	356,657	$4,940,000	—	31 Dec 2021	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.14%	340,779	$4,720,000	—	31 Dec 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.13%	327,532	$4,536,000	—	31 Dec 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.12%	313,268	$4,339,000	—	31 Dec 2021	13F
FIRST TRUST ADVISORS LP	13F	Company	0.12%	305,751	$4,235,000	—	31 Dec 2021	13F
Biondo Investment Advisors, LLC	13F	Company	0.11%	269,580	$3,734,000	—	31 Dec 2021	13F
SG Americas Securities, LLC	13F	Company	0.11%	266,215	$3,687,000	—	31 Dec 2021	13F
Allianz Asset Management GmbH	13F	Company	0.1%	263,115	$3,642,000	—	31 Dec 2021	13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q1 2022

As of 31 Mar 2022, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 219 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 127,644,333 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, FMR LLC, STATE STREET CORP, PICTET ASSET MANAGEMENT SA, Fisher Asset Management, LLC, RP Management, LLC, VICTORY CAPITAL MANAGEMENT INC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 219 institutional shareholders reporting positions in this security for the Q1 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders

197

Q1 2022 holders

219

Holder diff

Investor	Q4 2021 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q4 2021 Value $	Q1 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.